PubRank

M S Favero

Author PubWeight™ 116.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pseudomonas aeruginosa: growth in distilled water from hospitals. Science 1971 3.82
2 Use of laminar air-flow equipment in microbiology. Appl Microbiol 1968 3.79
3 Use of ultrasonic energy in assessing microbial contamination on surfaces. Appl Microbiol 1967 3.46
4 Microbiological sampling of surfaces. J Appl Bacteriol 1968 3.18
5 Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol 1978 2.64
6 Survival of hepatitis B virus after drying and storage for one week. Lancet 1981 2.60
7 Feasibility of using ultrasonics for removing viable microorganisms from surfaces. Contam Control 1967 2.54
8 Comparative levels and types of microbial contamination detected in industrial clean rooms. Appl Microbiol 1966 2.53
9 Factors affecting comparative resistance of naturally occurring and subcultured Pseudomonas aeruginosa to disinfectants. Appl Microbiol 1972 2.47
10 Gram-negative water bacteria in hemodialysis systems. Health Lab Sci 1975 2.28
11 Dry-heat inactivation kinetics of naturally occurring spore populations. Appl Microbiol 1970 2.27
12 Morphological, biochemical, and growth characteristics of pseudomonas cepacia from distilled water. Appl Microbiol 1973 2.05
13 Microbiologic assay of space hardware. Environ Biol Med 1971 1.90
14 Relative frequency distribution of d(125 C) values for spore isolates from the mariner-Mars 1969 spacecraft. Appl Microbiol 1971 1.72
15 Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol 1988 1.67
16 Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals. J Clin Microbiol 1983 1.66
17 Viral hepatitis B: aspects of environmental control. Health Lab Sci 1977 1.64
18 Susceptibility of vancomycin-resistant enterococci to environmental disinfectants. Infect Control Hosp Epidemiol 1997 1.63
19 Transmission of blood-borne pathogens during sports: risk and prevention. Ann Intern Med 1995 1.59
20 Microbial growth and endotoxin production in the intravenous anesthetic propofol. Infect Control Hosp Epidemiol 1991 1.49
21 CDC Guideline for Handwashing and Hospital Environmental Control, 1985. Infect Control 1986 1.41
22 Intrinsic bacterial contamination of a commercial iodophor solution: investigation of the implicated manufacturing plant. Appl Environ Microbiol 1984 1.40
23 Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. J Clin Microbiol 1988 1.37
24 Whirlpool spa-associated infections: are we really in hot water? Am J Public Health 1984 1.36
25 Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes. J Clin Microbiol 1989 1.34
26 Efficacy of chemical dosing methods for isolating nontuberculous mycobacteria from water supplies of dialysis centers. Appl Environ Microbiol 1988 1.33
27 Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl Environ Microbiol 1976 1.30
28 A combination medium for demonstrating starch and gelatin hydrolysis. Am J Med Technol 1968 1.28
29 Microbial contamination of renal dialysis systems and associated health risks. Trans Am Soc Artif Intern Organs 1974 1.27
30 Factors influencing the occurrence of high numbers of iodine-resistant bacteria in iodinated swimming pools. Appl Microbiol 1966 1.27
31 Microbiologic indicators of health risks associated with swimming. Am J Public Health 1985 1.27
32 Evaluation of a finger prick blood collection method for the seroepidemiology of hepatitis B. Bull World Health Organ 1978 1.25
33 Pyrogenic reactions during haemodialysis caused by extramural endotoxin. Lancet 1975 1.24
34 Iodine--champagne in a tin cup. Infect Control 1982 1.24
35 Bacillus sp. ATCC 27380: a spore with extreme resistance to dry heat. Appl Microbiol 1973 1.22
36 Factors associated with Pseudomonas pickettii intrinsic contamination of commercial respiratory therapy solutions marketed as sterile. Appl Environ Microbiol 1985 1.20
37 Detection methods for study of the stability of hepatitis B antigen on surfaces. J Infect Dis 1974 1.16
38 Effect of disinfectants on pseudomonads colonized on the interior surface of PVC pipes. Am J Public Health 1990 1.16
39 The colonization of solid PVC surfaces and the acquisition of resistance to germicides by water micro-organisms. J Appl Bacteriol 1993 1.13
40 Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. Lymphokine Cytokine Res 1993 1.10
41 Comparison of chemical dehydration and critical point drying for the stabilization and visualization of aging biofilm present on interior surfaces of PVC distribution pipe. J Appl Bacteriol 1996 1.10
42 Letter: Hepatitis-B antigen on environmental surfaces. Lancet 1973 1.07
43 CDC guidelines for the prevention and control of nosocomial infections. Guideline for handwashing and hospital environmental control, 1985. Supersedes guideline for hospital environmental control published in 1981. Am J Infect Control 1986 1.07
44 Transmission of hepatitis B virus. Semin Liver Dis 1981 1.04
45 Bacterial endotoxin in new and reused hemodialyzers: a potential cause of endotoxemia. Trans Am Soc Artif Intern Organs 1981 1.01
46 Bacteriological evaluation of an ultra-pure water-distilling system. Appl Microbiol 1975 1.01
47 Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A, non-B hepatitis. Infect Control 1985 0.99
48 Application of multilocus enzyme electrophoresis to epidemiologic investigations of Xanthomonas maltophilia. Infect Control Hosp Epidemiol 1991 0.97
49 Investigations of intrinsic Pseudomonas cepacia contamination in commercially manufactured povidone-iodine. Infect Control Hosp Epidemiol 1991 0.97
50 Bacterial and endotoxin permeability of hemodialysis membranes. Kidney Int 1979 0.96
51 Potential bacteriologic and endotoxin hazards associated with liquid bicarbonate concentrate. ASAIO Trans 1987 0.95
52 Air sampling for hepatitis B surface antigen in a dental operatory. J Am Dent Assoc 1979 0.94
53 Dialysis encephalopathy and aluminum exposure: an epidemiologic analysis. J Chronic Dis 1983 0.94
54 Comparison of microbial contamination levels among hospital operating rooms and industrial clean rooms. Appl Microbiol 1968 0.93
55 Factors that influence microbial contamination of fluids associated with hemodialysis machines. Appl Microbiol 1974 0.93
56 Transmission of type B viral hepatitis via eye inoculation of a chimpanzee. J Clin Microbiol 1982 0.91
57 Use of fecal coliform bacteria in evaluating microbial contamination in pediatric wards. Health Lab Sci 1970 0.91
58 Outbreak of pyrogenic reactions at a dialysis center. Association with infusion of heparinized saline solution. Am J Med 1983 0.91
59 Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors. Kidney Int 1992 0.91
60 Requiem for reuse of single-use devices in US hospitals. Infect Control Hosp Epidemiol 2001 0.90
61 Thermal profile of a Bacillus species (ATCC 27380) extremely resistant to dry heat. Appl Microbiol 1975 0.90
62 Method for collecting naturally occurring airborne bacterial spores for determining their thermal resistance. Appl Microbiol 1975 0.89
63 In vivo studies of dialysis-related endotoxemia and bacteremia. Nephron 1981 0.86
64 Reuse of hemodialyzers. Results of nationwide surveillance for adverse effects. JAMA 1988 0.86
65 Letter to the editor. Science 1972 0.84
66 Use of the Limulus amoebocyte lysate assay system for detection of bacterial endotoxin in fluids associated with hemodialysis procedures. Prog Clin Biol Res 1979 0.84
67 Guidelines for the care of patients hospitalized with viral hepatitis. Ann Intern Med 1979 0.83
68 Factors affecting endotoxin levels in fluids associated with hemodialysis procedures. Prog Clin Biol Res 1987 0.83
69 Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis 1986 0.83
70 Lack of plasma interleukin-1 beta or tumor necrosis factor-alpha elevation during unfavorable hemodialysis conditions. J Am Soc Nephrol 1991 0.82
71 Prolonged survival of Pseudomonas cepacia in commercially manufactured povidone-iodine. Appl Environ Microbiol 1990 0.82
72 Illness in hemodialysis patients after exposure to chloramine contaminated dialysate. ASAIO Trans 1992 0.81
73 National surveillance of dialysis-associated diseases in the United States, 1989. ASAIO Trans 1991 0.81
74 Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations. J Thorac Cardiovasc Surg 1992 0.81
75 Evaluation of a finger-stick specimen collection method for seroepidemiology of antibody to hepatitis A virus. J Clin Microbiol 1981 0.81
76 Comparison of microbiologic assay methods for hemodialysis fluids. J Clin Microbiol 1991 0.80
77 National surveillance of dialysis associated diseases in the United States--1994. ASAIO J 1997 0.80
78 National surveillance of dialysis associated diseases in the United States, 1992. ASAIO J 1995 0.80
79 Microbial contamination of mist therapy units on six pediatric wards. Health Lab Sci 1975 0.79
80 Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 1992 0.78
81 Thermoradiation inactivation of naturally occurring bacterial spores in soil. Appl Microbiol 1974 0.78
82 An air sampling technique for hepatitis B surface antigen. Health Lab Sci 1976 0.78
83 The effect of uremia on tumor necrosis factor-alpha release after an in vitro whole-blood endotoxin challenge. J Am Soc Nephrol 1994 0.78
84 A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 1992 0.77
85 Sterilization or disinfection of flexible fiberoptic endoscopes. AORN J 1979 0.76
86 Recovery of bacteria from reprocessed high flux dialyzers after bacterial contamination of the header spaces and O-rings. ASAIO Trans 1990 0.76
87 Effects of incubation time and temperature on microbiologic sampling procedures for hemodialysis fluids. J Clin Microbiol 1991 0.76
88 Effect of multiple use of dialyzers on hepatitis B incidence in patients and staff. JAMA 1981 0.76
89 EPA charges illegal claim for antibacterial-impregnated consumer products. Infect Control Hosp Epidemiol 1998 0.75
90 Infections transmitted by endoscopy: an international problem. Am J Infect Control 1996 0.75
91 Microbiologic evaluation of a new glutaraldehyde-based disinfectant for hemodialysis systems. Trans Am Soc Artif Intern Organs 1982 0.75
92 Effect of dispensers and hand antiseptic on hand hygiene. Infect Control Hosp Epidemiol 2000 0.75
93 The effects of endotoxin-contaminated dialysate and polysulfone or cellulosic membranes on the release of TNF alpha during simulated dialysis. Artif Organs 1995 0.75
94 National surveillance of dialysis associated diseases in the United States, 1991. ASAIO J 1994 0.75
95 Surveillance of unexplained illness and death. Infect Control Hosp Epidemiol 1998 0.75
96 Cost benefit of vaccination for hepatitis B in hemodialysis centers. J Infect Dis 1983 0.75
97 Potency of endotoxin from bicarbonate dialysate compared with endotoxins from Escherichia coli and Shigella flexneri. J Am Soc Nephrol 1995 0.75
98 Forum: disinfection & sterilization procedures used in hospitals in the U.S. Asepsis 1994 0.75
99 Congress approves needlestick safety bill. Infect Control Hosp Epidemiol 2000 0.75
100 APHA session features emerging infections. Emerg Infect Dis 1996 0.75
101 Progress of US hospitals in implementing TB control programs. Infect Control Hosp Epidemiol 1998 0.75
102 Are standards for dialysate purity in hemodialysis insufficiently strict? Semin Dial 2001 0.75
103 Multidose vial transmits HCV. Infect Control Hosp Epidemiol 2000 0.75
104 Effect of chemical germicides on the integrity of hemodialyzer membranes. ASAIO Trans 1989 0.75
105 Microbiological contamination control: a state of the art report. Contam Control 1965 0.75
106 AJPH welcomes significant laboratory studies. Am J Public Health 1979 0.75
107 Prevention and control of infections in specialized areas--viral hepatitis. CCQ 1980 0.75
108 Relationships between the prevalence of gastrointestinal disease and environmental contamination on a pediatric ward. Ariz Med 1970 0.75
109 National surveillance of dialysis-associated diseases in the United States, 1987. ASAIO Trans 1990 0.75
110 Strategies for disinfection and sterilization of endoscopes: the gap between basic principles and actual practice. Infect Control Hosp Epidemiol 1991 0.75
111 Aseptic peritonitis with home peritoneal dialysis. N Engl J Med 1977 0.75
112 National surveillance of dialysis associated diseases in the United States, 1993. ASAIO J 1997 0.75
113 Hepatitis B vaccine use in chronic hemodialysis centers in the United States. JAMA 1985 0.75
114 Bacteria and endotoxin removal from bicarbonate dialysis fluids for use in conventional, high-efficiency, and high-flux hemodialysis. Artif Organs 1992 0.75
115 National surveillance of dialysis-associated diseases in the United States, 1988. ASAIO Trans 1990 0.75
116 Favero: strategies to prevent transmission differ for patients, staff. Nephrol News Issues 1992 0.75
117 CJD update. Infect Control Hosp Epidemiol 1998 0.75
118 Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term hemodialysis. The Cooperative Dialysis Study Group. Am J Med 1991 0.75
119 Removal of bacteria and bacterial endotoxin from dialysis fluids by the media in a sorbent cartridge. Trans Am Soc Artif Intern Organs 1979 0.75
120 Stability of a reference panel of lyophilized hepatitis B antigens and antibodies. J Biol Stand 1979 0.75
121 National surveillance of hemodialysis associated diseases in the United States, 1990. ASAIO J 1993 0.75
122 Investigation of hemolytic anemia after chloramine exposure in a dialysis center. ASAIO Trans 1989 0.75
123 Enhanced release of TNF-alpha, but not IL-1 beta, from uremic blood after endotoxin stimulation. Lymphokine Cytokine Res 1991 0.75
124 Postdischarge surgical-site surveillance. Infect Control Hosp Epidemiol 1998 0.75
125 Transmission of HIV in dialysis units. ANNA J 1993 0.75